The Aperlena Verdict
Open raceNo supplier dominates: 132 different companies have won the last 298 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- -53.2%
- Expected final price vs the published estimate
Based on 298 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryA Czech public tender covers repeated supplies of medicinal products containing the active substance letermovir, an antiviral for systemic use. The buyer is located in Czechia. The notice does not specify the estimated value, the contracting authority's name, the submission deadline, or the award procedure, so these details are not stated here. Suppliers of medicines who meet the tender's qualification requirements may bid under the applicable EU public procurement rules. Interested businesses should consult the full tender documents for exact dates, conditions, and participation requirements before preparing an offer.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 3 weeks ago
More from this buyer
Full buyer profile45 open tenders right now
- Czech Republic - Antineoplastic and immunomodulating agents - INTERFERON BETA-1A 2026 1 day left
- Czech Republic - Construction modifications of healthcare facilities - Building works for buildings H1 and H2 2 days left
- Czech Republic - Architectural, construction, engineering and inspection services - PD - Building Permit Design for Buildings A and D 2 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Alliance Healthcare s.r.o. | 28 | €17.6M | Aug 2026 |
| PHOENIX lékárenský velkoobchod, s.r.o. | 26 | €17.9M | Aug 2026 |
| PHARMOS, a.s. | 12 | €4.9M | Jun 2026 |
| PROMEDICA PRAHA GROUP, a.s. | 11 | €3.9M | Aug 2026 |
| Boston Scientific Česká republika s.r.o. | 10 | €3.5M | Aug 2026 |
Based on 298 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 301 comparable contracts this buyer awarded in this sector over the last 4 years.
- €83,421
- Lower quartile
- €185,877
- Median award
- €589,945
- Upper quartile
This tender is estimated 220.8% above that median
Most recent awards
- Česko - Antineoplastika - LP s obsahem pirtobrutinibu 2026 €644,580
- Česko - Antineoplastika - LP s obsahem izatuximabu 2026 €1,953,942
- Česko - Chirurgické implantáty - Implantát k léčbě prolapsu pánevního dna €60,694
- Česko - Katétry - Katétr CVC 5 lumen antibakteriální vč. setu rouškovacího €50,852
- Česko - Anestetika - LP s obsahem fentanylu 2026 II. €454,249
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
1
day left
€119,738
est. value
1
day left
€12,421
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,211,630
- Buyer track record on Aperlena
- 774 notices tracked · 410 awarded
- €680,926,732 in awarded contracts
Never miss a tender like this
172 new notices in Medical equipment & pharmaceuticals in Czechia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert